Oxaliplatin [clinicaltrials_resource:e5d1d9d69e5a334e2308d47a3c77db8d]
condition [clinicaltrials_vocabulary:condition]
Oxaliplatin in Cancer Patients With Impaired Kidney Function [clinicaltrials:NCT00001835]Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer [clinicaltrials:NCT00003287]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]clinicaltrials:NCT00003594Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer [clinicaltrials:NCT00003799]clinicaltrials:NCT00003834clinicaltrials:NCT00004126clinicaltrials:NCT00004127Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00004173]Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer [clinicaltrials:NCT00004187]clinicaltrials:NCT00004190clinicaltrials:NCT00004203Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00004206]Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004220]Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00004242]Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor [clinicaltrials:NCT00004243]Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer [clinicaltrials:NCT00004257]Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer [clinicaltrials:NCT00004931]Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00005035]Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005036]Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005050]Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00005068]Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction [clinicaltrials:NCT00005077]Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy [clinicaltrials:NCT00005836]Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer [clinicaltrials:NCT00005837]Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor [clinicaltrials:NCT00005839]Oxaliplatin in Treating Children With Advanced Solid Tumors [clinicaltrials:NCT00005844]Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00005856]Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum [clinicaltrials:NCT00005860]clinicaltrials:NCT00006015Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver [clinicaltrials:NCT00006050]Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction [clinicaltrials:NCT00006062]Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum [clinicaltrials:NCT00006094]Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006115]Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [clinicaltrials:NCT00006117]Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [clinicaltrials:NCT00006121]Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00006391]Combination Chemotherapy in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00006465]Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006468]Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00006473]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Oxaliplatin [clinicaltrials_resource:e5d1d9d69e5a334e2308d47a3c77db8d]
Bio2RDF identifier
e5d1d9d69e5a334e2308d47a3c77db8d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e5d1d9d69e5a334e2308d47a3c77db8d
identifier
clinicaltrials_resource:e5d1d9d69e5a334e2308d47a3c77db8d
title
Oxaliplatin
@en
type
label
Oxaliplatin [clinicaltrials_resource:e5d1d9d69e5a334e2308d47a3c77db8d]
@en